EPILEPTIC ENCEPHALOPATHY
Clinical trials for EPILEPTIC ENCEPHALOPATHY explained in plain language.
Never miss a new study
Get alerted when new EPILEPTIC ENCEPHALOPATHY trials appear
Sign up with your email to follow new studies for EPILEPTIC ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare seizure sufferers: Long-Term drug safety confirmed
Disease control CompletedThis study looked at the long-term safety of a drug called fenfluramine (ZX008) for people with rare seizure disorders like Dravet syndrome and Lennox-Gastaut syndrome. Over 400 participants who had already been in earlier studies took the drug for an extended period. The main go…
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated May 26, 2026 11:28 UTC
-
New drug shows promise for kids with Sleep-Related epilepsy
Symptom relief CompletedThis study tested a new medicine called NBI-827104 in 24 children with a rare form of epilepsy that causes constant brain activity during sleep. The goal was to see if the drug could reduce that activity and improve safety. Children took the drug or a placebo once daily for 13 we…
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated May 26, 2026 11:33 UTC
-
Healthy volunteers help test Easier-to-Take seizure drug
Knowledge-focused CompletedThis study tested two versions of the seizure drug stiripentol (capsules vs. a liquid suspension) in 24 healthy adults to see if they work the same in the body. The goal is to offer a more convenient option for people with Dravet syndrome, a severe childhood epilepsy. Participant…
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Phase: PHASE1 • Sponsor: Biocodex • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC